Office-Based Asthma Screening Intervention - Full Text View

Sponsors and Collaborators:	University of Rochester Halcyon Hill Foundation Robert Wood Johnson Foundation
Information provided by:	University of Rochester
ClinicalTrials.gov Identifier:	NCT00156468

Purpose

In prior work, we found that even children who have been seen by their physicians within the prior six months were frequently misclassified as having mild rather than persistent asthma. This study evaluations whether systematic office-based screening assists primary care physicians in identifying children with significant asthma and improves preventive care for asthma. We hypothesize that standardized screening in the office setting will improve the physician’s ability to (a) identify children with significant asthma and (b) prescribe appropriate preventive medications.

Condition	Intervention
Asthma	Behavioral: Provider Prompt

MedlinePlus related topics: Asthma

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Single Blind, Active Control, Parallel Assignment
Official Title:	Office-Based Asthma Screening Intervention

Further study details as provided by University of Rochester:

Primary Outcome Measures:

"Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.

Secondary Outcome Measures:

Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.

Estimated Enrollment:	365
Study Start Date:	October 2003
Estimated Study Completion Date:	September 2005

Eligibility

Ages Eligible for Study:	2 Years to 12 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Children ages 2-12
Children arriving for an office visit in two Rochester, NY pediatric clinics
Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years

Exclusion Criteria:

Children arriving at the office visit with an adult that is not their parent or guardian
Children arriving at the office visit with a parent or guardian that does not speak English
Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00156468

Locations

United States, New York
University of Rochester
Rochester, New York, United States, 14642

Sponsors and Collaborators

University of Rochester

Halcyon Hill Foundation

Robert Wood Johnson Foundation

Investigators

Principal Investigator:

Jill S Halterman, MD, MPH

University of Rochester

More Information

Study ID Numbers:	10035
Study First Received:	September 8, 2005
Last Updated:	September 6, 2006
ClinicalTrials.gov Identifier:	NCT00156468
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Hypersensitivity
Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases

Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

Additional relevant MeSH terms:

Immune System Diseases
Bronchial Diseases

ClinicalTrials.gov processed this record on January 15, 2009